Marques Tiago
Chief Executive Officer
Marques Tiago has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 1, 2025.
On the most recent filing, Marques Tiago is listed as Chief Executive Officer at Pasithea Therapeutics Corp. Inside the rolling window, Marques Tiago reported 1 open-market purchase totaling $25K in KTTA and no open-market sales.
Companies traded
Other insiders at KTTA
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Marques Tiago made?
Marques Tiago has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Marques Tiago trade?
Marques Tiago has filed SEC Form 4 disclosures for 1 company, including KTTA.
When was Marques Tiago's most recent SEC Form 4 filing?
Marques Tiago's most recent SEC Form 4 filing on Tracefour is dated Dec 1, 2025.
What is Marques Tiago's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Marques Tiago is listed as Chief Executive Officer.
What is Marques Tiago's total buy and sell value in the current window?
Inside the rolling retention window, Marques Tiago bought $25K and sold $0 based on SEC Form 4 filings.
What was Marques Tiago's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 33,333 KTTA shares on 2025-11-28, worth $25K, per SEC Form 4 filings.